Top Markets
Coin of the day
Genix Pharmaceuticals Corporation Genix Pharmaceuticals Corporation

Genix Pharmaceuticals Corporation

GENPF
株式のランク #38709
Genix Pharmaceuticals Corporation, established in 1993 and headquartered in... Genix Pharmaceuticals Corporation, established in 1993 and headquartered in Vancouver, Canada, is actively involved in the creation, production, licensing, and distribution of various life science products. The company's primary focus in the Canadian market is on nutraceuticals and pharmaceuticals. Their product pipeline features several key developments: Flu-X: An herbal treatment available as an oral solution or spray, targeting viral infections, influenza, and coronaviruses responsible for common colds. Renochlor: A nutritional supplement formulated to support the revitalization and maintenance of kidney health and function. Sucanon: An insulin sensitizer designed to reduce blood sugar by improving the sensitivity of muscle, fat, and liver cells to insulin. Beyond these, Genix Pharmaceuticals also offers a wide range of other nutraceuticals and pharmaceutical items. This selection includes supplements such as bee propolis capsules, liquid calcium softgels, seal oil softgels, marine lipid softgels, lecithin softgels, fish oil softgels, EPO softgels, and spirulina powder, alongside ophthalmic products like eye ointments and drops. The company operated under the name Alta Natural Herbs & Supplements Ltd. until it adopted its current identity, Genix Pharmaceuticals Corporation, in June 2019.
株価
$0.0138
最終同期: 2026-08-13
時価総額
$844.89K
変化(1日)
0.00%
変化(1年)
0.00%
CA
取引 Genix Pharmaceuticals Corporation (GENPF)

カテゴリー

Genix Pharmaceuticals Corporation(GENPF)のEPS
2026 時点のEPS TTM: 0
Genix Pharmaceuticals Corporationの最新の財務報告と株価によると、同社の現在のEPS(TTM)は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
Genix Pharmaceuticals CorporationのEPS履歴(2026から2026まで)
各年末時点のEPS
EPS 変化
提供された日付のデータは十分ではありません。